UK early adopters of such tech. Before you read further, let me...

UK early adopters of such tech. Before you read further, let me stress Painsense and Epat are different (epat tech more promising IMHO). Its like comparing apples and oranges. However, putting this out there for anyone that thinks epat is years away from commercialisation.

Case in point - Painsense -  an App-based CBT (Cognitive Behavioural Therapy) agent for supported self-management of persistent pain. It includes a range of features such as tension alerts, relaxation resources, medication tracking and the use of games to support engagement, goal-setting and adherence. The co has developed an app where patients have to enter feedback into questionnaires based on Cleeland’s Brief Pain Inventory  (similar to Abbey Scale), record notes and conversations etc. Doctors can then analyse this data to make effective recommendations or the app can help self management of pain. Have a look at this 2 min video -
http://pain-sense.co.uk/
As you can see a lot of manual work and user driven engagement required to make it work and still has won contracts with the UK Health services. Compare this to epat when it is rolled out to the wider market outside of babies and dementia patients. Eg: BUPA
New pain management tool set to save NHS Millions

Article posted on: February 16, 2015
52

STORY HIGHLIGHTS:

• PainSense is an App-based CBT agent for supported self-management of persistent pain.
• Development of PainSense Apps could help save the NHS around £20 million.
• "We are really excited to be working with clinical experts in Leeds and Heywood."

BRADFORD, UK - (HealthTech Wire / News) - A brand new innovative mobile App has been developed by ADI Healthcare (Advanced Digital Institute) to help patients manage their pain independently.
ADI Healthcare was awarded £885,942.00 from SBRI Healthcare after being chosen from a competitive bidding process to secure the funds. Development of PainSense Apps could help save the NHS around £20 million, in addition to helping patients manage their pain successfully without the need to access clinical services.
PainSense is an App-based CBT (Cognitive Behavioural Therapy) agent for supported self-management of persistent pain. It includes a range of features such as tension alerts, relaxation resources, medication tracking and the use of games to support engagement, goal-setting and adherence.  
ADI Healthcare has led the work with Dr F Cole, Prof Lewin and Pete Moore to improve the pathway for persistent pain.
PainSense App’s improve supported self-care and are integrated into GP / Providers systems allowing safe sharing of records across N3 secure systems. Initial pathway results have already shown a 20 per cent reduction in pain related medication, a 50 per cent reduction in GP consultations and a 27 per cent reduction in onward referrals to pain or orthopaedic services.
It has also seen 80 per cent of people saying that their personal goals for managing pain had been achieved.
John Eaglesham, Chief Executive of ADI, said: “The launch of the App is fantastic news for ADI, for our NHS partners, and for the people living with chronic pain. We are really excited to be working with clinical experts in Leeds and Heywood in implementing the PainSense pathway enabled by the new App and to further develop the suite of self-help digital products to support people with chronic pain.”
According to the British Pain Society more than £5 million people attend a UK GP each year suffering with chronic pain. With the introduction of the PainSense App, GPs and medical professionals can help to reduce clinical attendance and improve services for other patients.
Karen Livingstone, Director of SBRI Healthcare, said: “This funding growth is testament to the program’s success and reaffirms NHS England’s commitment to healthcare innovation and evidencing the contribution of the NHS to the wider economy.
“Through SBRI Healthcare we are seeing exciting new technologies and products that will bring a sea change in patient care. The program is also building successful business in the life science sector – vital for UK growth."
David Harson, Program Manager at ADI Healthcare, said: “Without SBRI funding it would have taken much longer to develop the proof of concept service and evaluation, and it is then difficult to see how we would have progressed to development of the commercial service without this investment.”

The official product launch will take place at the BPS Event on 21-23 April, the Kind Fund Digital Health Event in June along with the Birmingham and Manchester Commissioning Live Events 2015.
More information on the App can be found by visiting www.pain-sense.co.uk

As mentioned before both apps and tech are different but there is a market out there.